BriaCell Therapeutics Corp (BCTXW) — Long-term Investment Intensity
BriaCell Therapeutics Corp (BCTXW) has a Long-term Investment Intensity of 1.7% as of January 2026. Long-term investments of $582.46K represent 1.7% of total assets of $33.31 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BCTXW net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BriaCell Therapeutics Corp Long-term Investment Intensity (2017–2024)
This chart shows how BriaCell Therapeutics Corp's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2024. As of January 2026, the intensity stands at 1.7%, reflecting long-term investments of $582.46K against total assets of $33.31 Million USD. Also explore BCTXW total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for BriaCell Therapeutics Corp (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for BriaCell Therapeutics Corp from 2017 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BriaCell Therapeutics Corp market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 7.1% | $418.49K | $5.87 Million | ▲ +7.1 pp |
| 2023 | 0.0% | $2.00 | $27.16 Million | ▲ +0.0 pp |
| 2022 | 0.0% | $2.00 | $42.58 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $58.04 Million | ▼ 0.0 pp |
| 2020 | 0.0% | $2.00 | $478.31K | ▼ 0.0 pp |
| 2019 | 0.0% | $2.00 | $415.43K | ▲ +0.0 pp |
| 2018 | 0.0% | $2.00 | $2.28 Million | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $1.64 Million | — |